Ionis Pharmaceuticals (IONS) PT Lowered to $84 at Raymond James

September 8, 2026 12:43 PM

Raymond James analyst Tiago Fauth lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $84.00 (from $87.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found